Bessemer Group’s AngioDynamics ANGO Stock Holding History

Bessemer Group’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2K	Sell	180 -2	-1%	-$22	﹤0.01%	2345
2025 Q4	$2K	Hold	182	–	–	﹤0.01%	2385
2025 Q3	$2K	Buy	182 +2	+1%	+$19	﹤0.01%	2288
2025 Q2	$2K	Hold	180	–	–	﹤0.01%	2174
2025 Q1	$2K	Sell	180 -15	-8%	-$158	﹤0.01%	2202
2024 Q4	$2K	Hold	195	–	–	﹤0.01%	2181
2024 Q3	$2K	Buy	+195	New	+$1.41K	﹤0.01%	2161
2023 Q4	–	Sell	-352	Closed	-$3K	–	2132
2023 Q3	$3K	Buy	+352	New	+$2.93K	﹤0.01%	1831
2020 Q3	–	Sell	-94,300	Closed	-$959K	–	1347
2020 Q2	$959K	Hold	94,300	–	–	﹤0.01%	805
2020 Q1	$984K	Sell	94,300 -14,500	-13%	-$182K	﹤0.01%	612
2019 Q4	$1.74M	Sell	108,800 -2,100	-2%	-$32.1K	0.01%	604
2019 Q3	$2.04M	Buy	110,900 +11,000	+11%	+$215K	0.01%	514
2019 Q2	$1.97M	Buy	99,900 +1,900	+2%	+$38.7K	0.01%	537
2019 Q1	$2.24M	Buy	98,000 +23,717	+32%	+$515K	0.01%	427
2018 Q4	$1.5M	Buy	74,283 +31,687	+74%	+$656K	0.01%	474
2018 Q3	$926K	Sell	42,596 -9,404	-18%	-$209K	﹤0.01%	599
2018 Q2	$1.16M	Hold	52,000	–	–	﹤0.01%	541
2018 Q1	$897K	Hold	52,000	–	–	﹤0.01%	610
2017 Q4	$865K	Sell	52,000 -11,200	-18%	-$191K	﹤0.01%	650
2017 Q3	$1.08M	Buy	63,200 +7,700	+14%	+$129K	﹤0.01%	632
2017 Q2	$900K	Buy	55,500 +2,100	+4%	+$33.2K	﹤0.01%	701
2017 Q1	$926K	Buy	53,400 +3,700	+7%	+$61.9K	﹤0.01%	731
2016 Q4	$838K	Buy	49,700 +12,700	+34%	+$212K	﹤0.01%	765
2016 Q3	$649K	Buy	+37,000	New	+$600K	﹤0.01%	702

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Broadfin Holdings Melville, New York $23.5M AUM

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

WCM

Weber Capital Management San Francisco, California $100M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAM

Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

Bessemer Group's ANGO Position: Q1 2026 in Review

Bessemer Group reduced its AngioDynamics (ANGO) stake by 1.1% in Q1 2026, selling an estimated $22 and leaving 180 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #2345.

Bessemer Group first reported a position in ANGO in Q3 2016 and has held it in 24 quarters since. The position peaked at $2.24M in Q1 2019. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

Bessemer Group held 180 shares of AngioDynamics worth $2K as of Q1 2026.
Bessemer Group sold 2 AngioDynamics shares in Q1 2026, an estimated $22.
AngioDynamics made up ﹤0.01% of Bessemer Group's portfolio in Q1 2026, its #2345 holding.
Bessemer Group first reported a position in AngioDynamics in Q3 2016 and has held it in 24 quarters since.
Bessemer Group's AngioDynamics position peaked at $2.24M in Q1 2019.
147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Bessemer Group's 13F filing for Q1 2026, filed 6 May 2026.